Thus, MLC601 and MLC901 reduce infarct size and ischemia-induced neurological deficits, attenuate cerebral ischemia-induced pro-inflammatory cellular infiltration, and attenuate stroke-induced increased expression of pro -inflammatory mediators (IL11, IL1β, IL6 and TNFα) in the brain [12]. The gene discussed is IL6; the disease is stroke disorder.